<DOC>
	<DOC>NCT00847249</DOC>
	<brief_summary>The aims of the study are to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD9164 following single ascending dose administrations to healthy male subjects.</brief_summary>
	<brief_title>AZD9164 Single Ascending Dose Study in Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Provision of signed, written and dated informed consent prior to any study specific procedures Have a body mass index (BMI) between 19 and 30 kg/m2 and weigh at least 50 kg and no more than 100 kg Be nonsmoker or exsmoker who has stopped smoking (or using other nicotine products) for &gt;6 months prior to study start Any clinically significant disease or disorder Any clinically significant abnormalities at screening examinations Use of any prescribed or nonprescribed medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>inhalation</keyword>
	<keyword>Healthy males</keyword>
</DOC>